Novartis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. 

CEO
Vasant Narasimhan
CEOVasant Narasimhan
Employees
75,267
Employees75,267
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1996
Founded1996
Employees
75,267
Employees75,267

NVS Key Statistics

Market cap
313.26B
Market cap313.26B
Price-Earnings ratio
21.25
Price-Earnings ratio21.25
Dividend yield
2.00%
Dividend yield2.00%
Average volume
1.76M
Average volume1.76M
High today
$154.81
High today$154.81
Low today
$152.91
Low today$152.91
Open price
$153.42
Open price$153.42
Volume
2.63M
Volume2.63M
52 Week high
$170.46
52 Week high$170.46
52 Week low
$97.72
52 Week low$97.72

NVS News

TipRanks 4d
Novartis announces two-year results from Phase III APPLAUSE-IgAN study

Novartis (NVS) announced final two-year results from the Phase III APPLAUSE-IgAN study of Fabhalta in IgA nephropathy, IgAN. Fabhalta demonstrated a statistical...

Benzinga 7d
Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline

Novartis Expands Allergy Portfolio IgE-driven (IgE-mediated) diseases are type I hypersensitivity reactions where immunoglobulin E antibodies trigger mast cell...

Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline
TipRanks 7d
Novartis to buy biotech company Excellergy for up to $2B

Novartis (NVS) announced that it has entered into an agreement to acquire Excellergy, Inc., a private biotech company developing next-generation anti-IgE therap...

Analyst ratings

43%

of 28 ratings
Buy
39.3%
Hold
42.9%
Sell
17.9%

More NVS News

TipRanks 7d
Novartis Stock Rises on $2B Excellergy Acquisition to Expand Allergy Portfolio

Shares of Swiss drugmaker Novartis (NVS) are slightly up in pre-market hours today after the company announced the acquisition of U.S.-based biotech company Exc...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.